Literature DB >> 12471629

Evidence against involvement of p53 polymorphism in breast cancer predisposition.

Evgeny N Suspitsin, Konstantin G Buslov, Maxim Yu Grigoriev, Julia G Ishutkina, Julia M Ulibina, Victoria M Gorodinskaya, Kazymir M Pozharisski, Lev M Berstein, Kaido P Hanson, Alexandr V Togo, Evgeny N Imyanitov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12471629     DOI： 10.1002/ijc.10834

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  18 in total

Review 1.  Evaluating cancer epidemiologic risk factors using multiple primary malignancies.

Authors:  Ekatherina Kuligina; Anne Reiner; Evgeny N Imyanitov; Colin B Begg
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

2.  TLR2∆22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India.

Authors:  K Rekha Devi; Saia Chenkual; Gautam Majumdar; Jishan Ahmed; Tanvir Kaur; Jason C Zonunmawia; Kaustab Mukherjee; Rup Kumar Phukan; Jagdish Mahanta; S K Rajguru; Debdutta Mukherjee; Kanwar Narain
Journal:  Tumour Biol       Date:  2015-07-19

3.  P53 gene polymorphisms and breast cancer risk in Arab women.

Authors:  Shafika Alawadi; Lina Ghabreau; Mervat Alsaleh; Zainab Abdulaziz; Mohamed Rafeek; Nizar Akil; Moussa Alkhalaf
Journal:  Med Oncol       Date:  2010-05-05       Impact factor: 3.064

4.  Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.

Authors:  Mustafa Akkiprik; Ozgur Sonmez; Bahadir M Gulluoglu; Hale B Caglar; Handan Kaya; Pakize Demirkalem; Ufuk Abacioglu; Meric Sengoz; Aydin Sav; Ayse Ozer
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

5.  Intron 3 sixteen base pairs duplication polymorphism of p53 contributes to breast cancer susceptibility: evidence from meta-analysis.

Authors:  Dongmei Wu; Zhizhong Zhang; Haiyan Chu; Ming Xu; Yao Xue; Haixia Zhu; Zhengdong Zhang
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis.

Authors:  Lin Zhao; Xiang-Xiongyi Yin; Jun Qin; Wei Wang; Xiao-Feng He
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.599

7.  Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

Authors:  Chaymaa Marouf; Amal Tazzite; Brehima Diakité; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Tumour Biol       Date:  2014-09-09

8.  p53 codon 72 polymorphism and breast cancer risk: A meta-analysis.

Authors:  Jing Hou; Yuan Jiang; Wenru Tang; Shuting Jia
Journal:  Exp Ther Med       Date:  2013-03-20       Impact factor: 2.447

9.  Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.

Authors:  Sandra Costa; Daniela Pinto; Deolinda Pereira; Helena Rodrigues; Jorge Cameselle-Teijeiro; Rui Medeiros; Fernando Schmitt
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

10.  Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.

Authors:  Sailesh Gochhait; Syed Irfan Ahmad Bukhari; Narendra Bairwa; Shivani Vadhera; Katayoon Darvishi; Mohammad Raish; Pawan Gupta; Syed Akhtar Husain; Rameshwar N K Bamezai
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.